About us What we do What we do Solving Kids’ Cancer fights for a future where no child dies of the childhood cancer neuroblastoma or suffers due to its treatment. We do this in a number of ways: Family support We are there for families of children affected by neuroblastoma, providing support throughout their cancer journey and helping them with the widespread challenges they face. Access to treatment We provide evidence-based and impartial information to help families choose treatment options for their child and to access treatments and clinical trials if they are not available on the NHS. Research We enable innovative clinical research, bringing more, better and less toxic treatment options to the UK for children fighting neuroblastoma now. Through this, we are determined to advance science and find a cure for future generations. Campaigning We campaign and collaborate with the neuroblastoma community for the best treatment and care for children in the UK. Watch our film Our history Solving Kids' Cancer started out as a foundation called the 2Simple Trust, set up in April 2006 to help a little boy called Jack Brown access a clinical trial in the USA to continue his neuroblastoma treatment. Jack had run out of treatment options here in the UK. The success of Jack’s fundraising campaign saw the charity grow to help more and more families in need. Sadly, Jack passed away in 2009 but the 2Simple Trust's expansion culminated in becoming the Neuroblastoma Children’s Cancer Alliance UK in September 2011, where our role soon after expanded from fundraising support for families to encompass broader family support, plus funding for cutting edge research. In 2015, years of interaction, sharing resources and working together on research projects with the New York charity, Solving Kids’ Cancer, saw us change our name to Solving Kids’ Cancer (Europe). In recent years we became the first charity to ever successfully appeal a NICE decision and subsequently led a coalition of 13 other charities to campaign for the approval of immunotherapy treatment for children affected by neuroblastoma in the UK. Our five-year strategy Read Solving Kids' Cancer's first five-year strategy, published in 2017.